Last reviewed · How we verify

NCT03096639: RESCUE2

Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing

Completed NA Last updated 16 November 2022
What this trial tests

NA trial testing Diaphragmatic Pacing Therapy DPTS in Ventilator Induced Diaphragm Dysfunction in 110 participants. Completed in 30 January 2020.

Timeline
14 September 2017
Primary endpoint
29 December 2019
30 January 2020

Quick facts

Lead sponsorLungpacer Medical Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment110
Start date14 September 2017
Primary completion29 December 2019
Estimated completion30 January 2020
Sites21 locations across France, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Lungpacer Medical Inc. — full company profile →

Who can join

18 and older, any sex, with Ventilator Induced Diaphragm Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized clinical trial to investigate the use of the temporary Diaphragm Pacing Therapy System (DPTS) to rehabilitate the diaphragm in mechanically ventilated patients who have failed at least two weaning attempts. The goal is to strengthen and rehabilitate the diaphragm to liberate the patient more quickly from mechanical ventilation.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort.
    Goligher EC, Jonkman AH, Dianti J, Vaporidi K, et al · · 2020 · cited 118× · PMID 33140181 · DOI 10.1007/s00134-020-06288-9
  2. Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients.
    Dres M, de Abreu MG, Merdji H, Müller-Redetzky H, et al · · 2022 · cited 54× · PMID 35108175 · DOI 10.1164/rccm.202107-1709oc
  3. Ventilator-induced diaphragm dysfunction: translational mechanisms lead to therapeutical alternatives in the critically ill.
    Peñuelas O, Keough E, López-Rodríguez L, Carriedo D, et al · · 2019 · cited 39× · PMID 31346802 · DOI 10.1186/s40635-019-0259-9
  4. Temporary transvenous diaphragm pacing vs. standard of care for weaning from mechanical ventilation: study protocol for a randomized trial.
    Evans D, Shure D, Clark L, Criner GJ, et al · · 2019 · cited 21× · PMID 30654837 · DOI 10.1186/s13063-018-3171-9
  5. Ventilator-induced diaphragm dysfunction in critical illness.
    Liu YY, Li LF. · · 2018 · cited 19× · PMID 30453774 · DOI 10.1177/1535370218811950
  6. Breath-synchronized electrical stimulation of the expiratory muscles in mechanically ventilated patients: a randomized controlled feasibility study and pooled analysis.
    Jonkman AH, Frenzel T, McCaughey EJ, McLachlan AJ, et al · · 2020 · cited 10× · PMID 33126902 · DOI 10.1186/s13054-020-03352-0
  7. The COPD Pipeline XXXV.
    Gross N. · · 2017 · PMID 28848935 · DOI 10.15326/jcopdf.4.3.2017.0154

Verify or expand the search:

Other Lungpacer Medical Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03096639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing